Skip to content

Company information lookup

ACTINOGEN LIMITED (ACW)

Commercialisation of bioactive compounds

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACW 0.041 -6.82% 0.042 0.045 0.041 0.041 0.041 34,000
(Status - RE)

ACTINOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACW
Securities
Official Listing Date 16 October, 2007
GICS Industry Group Materials
Exempt Foreign? No
Internet Address http://www.actinogen.com.au
Registered Office Address Level 2, 1 Walker Avenue, WEST PERTH, WA, AUSTRALIA, 6005
Head Office Telephone +61 8 9481 3860
Head Office Fax +61 8 9321 1204
Share Registry AUTOMIC REGISTRY SERVICES
LEVEL 1, 7 VENTNOR AVENUE, WEST PERTH, WA, AUSTRALIA, 6005
Share Registry Telephone (08) 9324 2099
Directors / Senior Management
Mr Brendan De Kauwe (Executive Chairman)
Dr Jason Loveridge (Non Exec. Director)
Mr Daniel Parasiliti (Non Exec. Director)
Dr Anton Uvarov (Non Exec. Director)
Company Secretary Mr Peter Webse
Principal Activities Commercialisation of bioactive compounds

ACTINOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
12/09/2014   Appointment of Vice President of Clinical Research 1 PDF
03/09/2014   Change in Substantial Shareholding x 3 6 PDF
02/09/2014   Information Required under Asx Listing Rule 3.10.5A 1 PDF
02/09/2014   Section 708A Notice 1 PDF
02/09/2014   Appendix 3B -Share Placement 12 PDF
27/08/2014   Investor Presentation 19 PDF
27/08/2014   Appointment of Clinical Advisers 2 PDF
27/08/2014   Proposed Board Changes 3 PDF
27/08/2014 asterix Capital Raising 1 PDF
27/08/2014 asterix Actinogen to acquire Corticrine Limited 4 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
22 Sep 2014 0.044 -2.22% 0.045 0.044 402,000
19 Sep 2014 0.045 0% 0.045 0.045 50,000
18 Sep 2014 0.045 -8.16% 0.050 0.045 898,000
17 Sep 2014 0.049 -2% 0.050 0.049 100,000
16 Sep 2014 0.050 0% 0.050 0.050 200,000

* Volume of shares shown represents only those shares traded on ASX.

ACTINOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACW. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACW

Warrants & Structured Products

No warrants & Structured Products are available over the security ACW

ASX CFDs

No Contracts For Differences are available over the security ACW